Abbott India Limited (NSE:ABBOTINDIA)
27,945
+425 (1.54%)
May 15, 2026, 3:29 PM IST
Abbott India Company Description
Abbott India Limited operates as a pharmaceutical company in India.
It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, pain management, pre-term labor, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002.
Abbott India Limited was incorporated in 1944 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.
Abbott India Limited

| Country | India |
| Founded | 1910 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 3,659 |
| CEO | Kartik Rajendran |
Contact Details
Address: Godrej BKC, Bandra-Kurla Complex Mumbai, Maharashtra Maharashtra India | |
| Phone | 91 22 5046 1000 |
Stock Details
| Ticker Symbol | ABBOTINDIA |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE358A01014 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Kartik Rajendran | MD and Director |
| Maithilee Mistry | Chief Financial Officer |
| Sangeeta Mukesh Shetty | Associate Director - Secretarial, Company Secretary, Nodal Officer and Compliance Officer |
| Vinutha Mufti | Director of Business Human Resources |